Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HPV-6-targeting Immunotherapeutic Vaccine INO-3106

Known as: HPV-6 E6/E7 DNA Vaccine INO-3106, HPV-6-targeting Immunotherapeutic INO-3106, INO-3106 
A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the… Expand
  • figure 3
  • figure 4
Is this relevant?
2019
2019
Summary Trafficking of macromolecular immunotherapy agent into the tumor microenvironment (TME) is a challenging issue. In the… Expand
  • figure 1
Is this relevant?
2019
2019
Antibiotic-free methods hold particular promise for preventing and controlling multidrug-resistant (MDR) bacterial infection via… Expand
Is this relevant?
2016
2016
OBJECTIVE To investigate the correlation between the positive rate of high risk human papillomavirus(HPV)mRNA E6/E7 and cervical… Expand
Is this relevant?
2012
2012
Purpose: To evaluate IL13Ra2 as an immunotherapeutic target for eliminating glioma stem–like cancer initiating cells (GSC) of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
B7-H1 (B7 homologue 1, PD-L1), expressed on the surface of tumor cells or antigen-presenting cells in the tumor microenvironment… Expand
Is this relevant?